Waters reports Q2 earnings, cites commercial momentum

By The Science Advisory Board staff writers

August 4, 2021 -- Lab equipment supplier Waters reported that its second-quarter (end-June 30, 2021) sales rose by 31% to $682 million, up from $520 million in 2020.

Waters reported a non-generally accepted accounting principles (GAAP) adjusted free cash flow of $155 million, down from $175 million after funding $37 million in capital expenditures. Year to date, free cash flow increased by 17% to $348 million, the company reported.

On a GAAP basis, the company reported a diluted earnings per share of $2.69 in the second quarter, up from $1.98 for the same period in 2020. Non-GAAP earnings per share were $2.60 year over year from $2.10.

In its earnings report, Waters noted broad commercial momentum in pharmaceutical and industrial end markets, which were up by 34% and 31%, respectively, in the second quarter.

Waters is anticipating a sales growth rate of 13% to 15% for 2021 in constant currency.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.